CLM29, a multi-target pyrazolopyrimidine derivative, has anti-neoplastic activity in medullary thyroid cancer in vitro and in vivo.
| Image |  |
|---|---|
| Description | scientific article published on 12 June 2014 |
| Author/s |
author: Stefania Sartini Romano Danesi Federico Da Settimo Passetti Poupak Fallahi Salvatore Ulisse Gabriella Fontanini Simona Piaggi Concettina La Motta |
| Publication date | June 12, 2014 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |